Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome
- 16 October 2006
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 11 (6) , 715-722
- https://doi.org/10.1111/j.1440-1843.2006.00942.x
Abstract
Pathological changes in severe acute respiratory syndrome (SARS) suggest that SARS sequelae are associated with dysregulation of cytokine and chemokine production. To improve understanding of the immuno-pathological processes involved in lung injury associated with SARS, the temporal changes in cytokine/chemokine profiles in the sera of SARS patients were compared with those of patients with community-acquired pneumonia (CAP), according to the degree of lung involvement. Serum levels of 11 cytokines and chemokines, in 14 patients with SARS and 24 patients with CAP, were serially checked using a bead-based multiassay system. Sera from 12 healthy subjects were used as normal controls. The serum levels of interferon-gamma-inducible protein-10 (IP-10), IL-2 and IL-6 were significantly elevated during SARS infection. In patients with CAP, but not in those with SARS, the levels of interferon-gamma, IL-10, IL-8 and monokine induced by interferon-gamma (MIG) were significantly elevated compared with the levels in healthy controls. Among the chemokines/cytokines, IL-6 levels correlated most strongly with radiographic scores (r=0.62). The elevation of IP-10 and IL-2 antedated the development of chest involvement and reached peak levels earlier than the radiographic scores. In contrast, the dynamic changes in IL-6, C-reactive protein and neutrophils occurred synchronously with the changes in radiographic scores. The mean ratio of IL-6 to IL-10 in SARS patients (4.84; range 0.41-21) was significantly higher than that in CAP patients (2.95; range 0.02-10.57) (P=0.04). The early induction of IP-10 and IL-2, as well as the subsequent over-production of IL-6 and lack of IL-10 production, probably contribute to the main immuno-pathological processes involved in lung injury in SARS. These changes in cytokine/chemokine profile are remarkably different from those observed in CAP patients.Keywords
This publication has 35 references indexed in Scilit:
- Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cellsBlood, 2005
- An interferon‐γ‐related cytokine storm in SARS patientsJournal of Medical Virology, 2004
- Analysis of Serum Cytokines in Patients with Severe Acute Respiratory SyndromeInfection and Immunity, 2004
- Respiratory Syncytial Virus–Induced Chemokine Production: Linking Viral Replication to Chemokine Production In Vitro and In VivoThe Journal of Infectious Diseases, 2004
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- Induction of interferon-inducible protein-10 and monokine induced by interferon-? from human endothelial cells infected with Influenza A virusArchiv für die gesamte Virusforschung, 2003
- Developmental differences in the role of interleukins in hyperoxic lung injury in animal modelsFrontiers in Bioscience-Landmark, 2002
- Molecular Pathways in Virus-Induced Cytokine ProductionMicrobiology and Molecular Biology Reviews, 2001
- Cytokine expression in severe pneumonia: A bronchoalveolar lavage studyCritical Care Medicine, 1999
- Evidence for Cytokine Mediation of Disease Expression in Adults Experimentally Infected with Influenza A VirusThe Journal of Infectious Diseases, 1999